Genome Valley is an Indian high-technology business district, and global biopharmaceutical capability hub spread across 2,000-acre (8.1 km2)/(3.1 sq mi) in Hyderabad, India. It is located across the suburbs Turakapally, Shamirpet, Medchal, Uppal, Patancheru, Jeedimetla, Gachibowli and Keesara. The Genome Valley has developed as a cluster for Biomedical research, training and manufacturing. Genome Valley is now into its Phase III, which is about 11 km from the Phase I and II with the total area approximately 2,000-acre (8.1 km2).
History
The concept of Genome Valley was envisioned by Dr. Krishna Ella, the founder of Bharat Biotech. He proposed the idea of creating a dedicated biotech hub that would bring together research, development, and manufacturing facilities in the life sciences sector. Genome Valley was commissioned by the then combined Government of Andhra Pradesh in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank.
Alexandria Knowledge Park SEZ In 2009, U.S.-based infrastructure giant Alexandria Real Estate Equities has announced its plans to invest in the bio-cluster, which led to the Alexandria Knowledge Park SEZ. The bio-cluster at Shamirpet holds Certification mark by the United States Patent and Trademark Office and the European Union.
IKP Knowledge Park The IKP Knowledge Park is spread over 200 acres in Turakapally, is an initiative of ICICI Bank with five "innovation corridors" - a first of its kind knowledge-nurturing centre for Indian companies and a knowledge gateway for multinational companies". The first phase of Innovation Corridor I, comprising 10 laboratories, around 3,000 ft² (300 m²) each, is operational and fully occupied. The second phase of Innovation Corridor I, comprising 16 laboratory modules of 1,700 ft² (170 m²) each, is ready for operation.
Growth
Neovantage Innovation Parks In 2016, Mission Neutral Park acquired specialized R&D assets in Genome Valley from U.S.-based Alexandria REIT and rechristened it as MN Park. It was later rebranded as Neovantage Innovation Parks in 2023. Neovantage Innovation Parks is a collaborative life sciences ecosystem in Genome Valley, Hyderabad consisting of Grade A R&D facilities. Neovantage Innovation Parks is spread over 1,000,000 sq ft of space, including built-up facilities of around 850,000 sq.ft. provided to global tenants like Novartis, GlaxoSmithKline, Mylan and Ashland Inc. The campuses consist of pre-leased industrial assets and specialized office spaces to sectors including specialized warehousing, vaccine development, CROs, Bio-Pharma Production, pharmaceutical R&D etc.
Big Pharma and Global Capability Centers
Clinical and Healthcare IT
Manufacturing
R & D
Small Biotechs
See also
Hyderabad Pharma City Department of Biotechnology Pharmaceutical industry in India
References